US Stock MarketDetailed Quotes
PFE Pfizer
- 25.820
- -0.390-1.49%
Close Dec 2 16:00 ET
- 25.850
- +0.030+0.12%
Post 19:59 ET
146.32BMarket Cap34.43P/E (TTM)
26.220High25.730Low43.87MVolume26.070Open26.210Pre Close1.13BTurnover0.78%Turnover Ratio69.78P/E (Static)5.67BShares31.05752wk High1.59P/B146.11BFloat Cap24.10552wk Low1.67Dividend TTM5.66BShs Float53.878Historical High6.47%Div YieldTTM1.87%Amplitude5.393Historical Low25.864Avg Price1Lot Size
Pfizer Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 29, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Oct 1, 2023 | (Q2)Jul 2, 2023 | (Q1)Apr 2, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 94.13%6.71B | -47.31%-1.78B | -9.91%1.09B | -70.27%8.7B | -38.93%5.24B | -42.07%3.46B | -114.79%-1.21B | -81.49%1.21B | -11.10%29.27B | 44.70%8.58B |
| Net income from continuing operations | 287.65%4.48B | -98.68%31M | -43.69%3.13B | -93.08%2.17B | -166.69%-3.34B | -127.63%-2.39B | -76.31%2.34B | -29.50%5.56B | 39.81%31.4B | 39.77%5B |
| Depreciation and amortization | 12.50%1.76B | 10.04%1.73B | 16.75%1.74B | 24.21%6.29B | 9.94%1.67B | 31.87%1.56B | 33.87%1.57B | 25.27%1.49B | -2.45%5.06B | 13.78%1.52B |
| Deferred tax | -326.55%-482M | 10.31%-783M | 26.25%-441M | 8.55%-3.44B | -409.04%-1.86B | -282.26%-113M | 23.42%-873M | 74.24%-598M | 12.32%-3.76B | 46.56%-365M |
| Other non cash items | -46.69%-842M | 151.02%274M | -253.00%-353M | -970.00%-4.28B | -127.50%-3.07B | -228.00%-574M | -175.10%-537M | -124.45%-100M | 91.48%-400M | -47.27%-1.35B |
| Change In working capital | 173.31%879M | 9.73%-3.54B | 39.42%-3.34B | 61.48%-2.17B | 246.03%8.45B | 73.85%-1.2B | -41.58%-3.92B | -654.38%-5.51B | -144.04%-5.64B | 26.07%2.44B |
| -Change in receivables | ---- | ---- | ---- | 32.95%347M | ---- | ---- | ---- | ---- | 106.85%261M | ---- |
| -Change in inventory | ---- | ---- | ---- | -97.80%-1.17B | ---- | ---- | ---- | ---- | 47.47%-591M | ---- |
| -Change in payables and accrued expense | ---- | ---- | ---- | -125.19%-300M | ---- | ---- | ---- | ---- | -4.11%1.19B | ---- |
| -Change in other current assets | ---- | ---- | ---- | 85.29%-663M | ---- | ---- | ---- | ---- | -326.30%-4.51B | ---- |
| -Change in other current liabilities | ---- | ---- | ---- | 141.06%595M | ---- | ---- | ---- | ---- | -107.74%-1.45B | ---- |
| -Change in other working capital | ---- | ---- | ---- | -80.18%-982M | ---- | ---- | ---- | ---- | 53.26%-545M | ---- |
| Cash from discontinued investing activities | 0 | 0 | ||||||||
| Operating cash flow | 94.27%6.71B | -47.43%-1.78B | -10.07%1.09B | -70.27%8.7B | -38.94%5.24B | -42.15%3.46B | -114.79%-1.21B | -81.47%1.21B | -10.17%29.27B | 45.11%8.58B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -331.24%-2.06B | 118.05%4.6B | -47.80%1.73B | -104.50%-32.28B | -149.31%-11B | 242.40%890M | -125.26%-25.49B | 484.83%3.32B | 29.96%-15.78B | -70.84%-4.41B |
| Net PPE purchase and sale | 19.63%-651M | 30.31%-637M | 38.19%-704M | -20.74%-3.91B | -4.30%-1.04B | 3.69%-810M | -21.70%-914M | -77.14%-1.14B | -19.37%-3.24B | 0.10%-1B |
| Net business purchase and sale | --0 | --0 | --3.49B | -88.85%-43.43B | -158.79%-43.41B | --0 | ---25M | --0 | ---23B | ---16.77B |
| Net investment purchase and sale | -204.59%-1.41B | 121.88%5.26B | -123.61%-1.06B | 128.06%15.24B | 150.40%33.44B | 137.14%1.35B | -129.11%-24.02B | -39.94%4.47B | 134.24%6.68B | 911.79%13.35B |
| Net other investing changes | -98.28%6M | 96.37%-19M | 105.26%1M | 6.25%-180M | 66.67%15M | 413.51%348M | -580.52%-524M | -46.15%-19M | 37.25%-192M | -86.15%9M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -331.64%-2.06B | 118.05%4.6B | -47.75%1.73B | -104.51%-32.28B | -149.34%-11B | 241.63%888M | -125.27%-25.49B | 484.66%3.32B | 30.00%-15.78B | -70.53%-4.41B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -22.68%-4.64B | -109.05%-2.46B | -77.95%-4.93B | 275.72%26.07B | 208.51%5.44B | 34.40%-3.78B | 977.95%27.18B | 57.88%-2.77B | -51.12%-14.83B | -49.66%-5.02B |
| Net issuance payments of debt | -57.56%-2.25B | -100.05%-16M | -6,690.63%-2.17B | 1,122.33%35.95B | 379.98%7.78B | 59.44%-1.43B | 542.59%29.63B | 98.25%-32M | -218.77%-3.52B | -103.74%-2.78B |
| Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---2B | --0 |
| Cash dividends paid | -2.85%-2.38B | -2.81%-2.38B | -3.00%-2.37B | -2.94%-9.25B | -3.12%-2.32B | -3.07%-2.31B | -3.16%-2.32B | -2.40%-2.3B | -2.91%-8.98B | -2.56%-2.25B |
| Net other financing activities | 83.78%-6M | 55.32%-63M | 11.47%-386M | -88.66%-632M | -357.14%-18M | -840.00%-37M | -192.16%-141M | 12.80%-436M | -2,193.75%-335M | -96.52%7M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -22.68%-4.64B | -109.05%-2.46B | -77.95%-4.93B | 275.72%26.07B | 208.51%5.44B | 34.40%-3.78B | 978.33%27.17B | 57.87%-2.77B | -51.12%-14.83B | -49.66%-5.02B |
| Net cash flow | ||||||||||
| Beginning cash position | -58.38%1.12B | -64.90%780M | 523.29%2.92B | -76.40%468M | 141.63%3.23B | 47.92%2.7B | -11.58%2.22B | -76.40%468M | 8.66%1.98B | -34.22%1.34B |
| Current changes in cash | -96.47%20M | -24.95%361M | -220.10%-2.11B | 284.37%2.49B | 62.68%-315M | 236.96%567M | 177.21%481M | 230.70%1.76B | -722.12%-1.35B | -3,416.67%-844M |
| Effect of exchange rate changes | 128.13%9M | -260.00%-18M | -1,300.00%-28M | 75.76%-40M | 96.15%-1M | 55.56%-32M | 92.42%-5M | -100.00%-2M | -179.66%-165M | 3.70%-26M |
| End cash Position | -64.37%1.15B | -58.38%1.12B | -64.90%780M | 523.29%2.92B | 523.29%2.92B | 141.63%3.23B | 47.92%2.7B | -11.58%2.22B | -76.40%468M | -76.40%468M |
| Free cash flow | 129.14%6.06B | -13.95%-2.42B | 428.77%386M | -81.59%4.79B | -44.65%4.2B | -48.45%2.65B | -128.60%-2.12B | -98.76%73M | -12.85%26.03B | 54.34%7.58B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
